ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]

Circio and GenAssist have announced a research collaboration aimed at [...]

Circio has raised NOK 250 million in a significantly oversubscribed [...]

Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

SynGenSys has launched Liver.SET, a library of liver-specific synthetic promoters [...]